newsfilter
← Latest News
GlobeNewswire·

Surface Oncology to Participate in Citi's 2022 Virtual Immuno-Oncology Summit

CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that company management will